Companies / BioXcel Therapeutics, Inc. / Activity

Activity — BioXcel Therapeutics, Inc.

34 moves.

Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
InsidersInstitutions
DateActorActionSecurityValueShares ΔPosition afterImpact
May 20, 2026Steinhart Richard I
Executive
SellCommon Stock$7.4K-7K
-20.65%
26,300
0.09% of shares
low
Jun 15, 2026Steinhart Richard I
Executive
ExerciseRestricted Stock Units—-35
-14.17%
212
<0.01% of shares
low
Jun 15, 2026Steinhart Richard I
Executive
ExerciseCommon Stock—+35
+0.13%
26,335
0.09% of shares
low
May 4, 2026Steinhart Richard I
Executive
ExerciseRestricted Stock Units—-18K
-25.00%
52,500
0.17% of shares
low
May 4, 2026Steinhart Richard I
Executive
ExerciseCommon Stock—+18K
+111.86%
33,145
0.11% of shares
low
May 1, 2026Steinhart Richard I
Executive
ExerciseRestricted Stock Units—-9K
-100.00%
0
0.00% of shares
low
May 1, 2026Steinhart Richard I
Executive
ExerciseCommon Stock—+9K
+135.44%
15,645
0.05% of shares
low
Mar 15, 2026Rodriguez Javier
Executive
ExerciseRestricted Stock Units—-35
-12.41%
247
<0.01% of shares
low
Mar 14, 2026Rodriguez Javier
Executive
ExerciseRestricted Stock Units—-33
-25.38%
97
<0.01% of shares
low
Mar 15, 2026Rodriguez Javier
Executive
ExerciseCommon Stock—+35
+0.51%
6,863
0.02% of shares
low
Mar 14, 2026Rodriguez Javier
Executive
ExerciseCommon Stock—+33
+0.49%
6,828
0.02% of shares
low
Jan 1, 2026Rodriguez Javier
Executive
GrantRestricted Stock Units—+70K
+24822.69%
70,282
0.23% of shares
low
Jan 9, 2026Bray June
Director
GrantStock Option (Right to Buy)—+17K
17,000
0.06% of shares
low
Mar 15, 2026Mehta Vimal
CEO
ExerciseRestricted Stock Units—-219
-12.51%
1,532
<0.01% of shares
low
Mar 14, 2026Mehta Vimal
CEO
ExerciseRestricted Stock Units—-164
-25.15%
488
<0.01% of shares
low
Mar 15, 2026Mehta Vimal
CEO
ExerciseCommon Stock—+219
+1.04%
21,259
0.07% of shares
low
Mar 14, 2026Mehta Vimal
CEO
ExerciseCommon Stock—+164
+0.79%
21,040
0.07% of shares
low
Jan 1, 2026Mehta Vimal
CEO
GrantRestricted Stock Units—+199K
+11366.76%
200,783
0.65% of shares
low
Mar 15, 2026Yocca Frank
Executive
ExerciseRestricted Stock Units—-35
-12.41%
247
<0.01% of shares
low
Mar 14, 2026Yocca Frank
Executive
ExerciseRestricted Stock Units—-33
-25.38%
97
<0.01% of shares
low
Mar 15, 2026Yocca Frank
Executive
ExerciseCommon Stock—+35
+0.54%
6,520
0.02% of shares
low
Mar 14, 2026Yocca Frank
Executive
ExerciseCommon Stock—+33
+0.51%
6,485
0.02% of shares
low
Jan 1, 2026Yocca Frank
Executive
GrantRestricted Stock Units—+70K
+24822.69%
70,282
0.23% of shares
low
Jan 9, 2026Laumas Sandeep
Director
GrantStock Option (Right to Buy)—+17K
17,000
0.06% of shares
low
Mar 15, 2026Steinhart Richard I
Executive
ExerciseRestricted Stock Units—-35
-12.41%
247
<0.01% of shares
low
Mar 14, 2026Steinhart Richard I
Executive
ExerciseRestricted Stock Units—-33
-25.38%
97
<0.01% of shares
low
Mar 15, 2026Steinhart Richard I
Executive
ExerciseCommon Stock—+35
+0.53%
6,645
0.02% of shares
low
Mar 14, 2026Steinhart Richard I
Executive
ExerciseCommon Stock—+33
+0.50%
6,610
0.02% of shares
low
Jan 9, 2026Patni Rajiv
Director
GrantStock Option (Right to Buy)—+17K
17,000
0.06% of shares
low
Jan 9, 2026Mueller Peter
Director
GrantStock Option (Right to Buy)—+17K
17,000
0.06% of shares
low
Jan 9, 2026Votruba Michal
Director
GrantStock Option (Right to Buy)—+17K
17,000
0.06% of shares
low
Jan 9, 2026Miller Michael Patrick
Director
GrantStock Option (Right to Buy)—+17K
17,000
0.06% of shares
low
Jan 9, 2026Mack David J.
Director
GrantStock Option (Right to Buy)—+17K
17,000
0.06% of shares
low
Jan 1, 2026Steinhart Richard I
Executive
GrantRestricted Stock Units—+70K
+24822.69%
70,282
0.23% of shares
low
← PrevPage 1 of 1Next →